US 9034881
Treatment for vitiligo
granted A61KA61K31/145A61K31/505
Quick answer
US patent 9034881 (Treatment for vitiligo) held by Rigel Pharmaceuticals, Inc. expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/145, A61K31/505, A61K31/506, A61K45/06